市場調査レポート

ヘモグロビンA1c検査装置市場(エンドユース:試験所およびポイントオブケア検査装置、技術:イオン交換HPLC、免疫測定、ボロン酸親和性クロマトグラフィ、直接酵素アッセイその他) - 世界の業界分析、市場規模、シェア、成長、動向および予測

Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 301495
出版日 ページ情報 英文 94 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
ヘモグロビンA1c検査装置市場(エンドユース:試験所およびポイントオブケア検査装置、技術:イオン交換HPLC、免疫測定、ボロン酸親和性クロマトグラフィ、直接酵素アッセイその他) - 世界の業界分析、市場規模、シェア、成長、動向および予測 Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2014年04月30日 ページ情報: 英文 94 Pages
概要

当レポートでは、世界のヘモグロビンA1c検査装置市場について調査し、市場の概要と2013〜2019年の予測、地域別動向、参入企業のプロファイルをまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 世界のヘモグロビンA1c検査装置市場概要

  • イントロダクションと市場の定義
  • 市場促進因子
    • 糖尿病患者の増加
    • 高齢化
    • HbA1c検査の証明された利点が急速な導入につながってる
  • 市場阻害因子
    • 検査費用の高騰
    • 代用品の存在
  • 市場の機会
    • 新興市場における収益性の高い市場機会
    • 糖尿病診断装置の急速な商品化
  • ポーターズファイブフォース分析
  • 市場の魅力度分析
  • 競合環境

第4章 エンドユース別市場

  • 概要
  • 比較分析
  • 試験所検査装置
  • ポイントオブケア検査装置

第5章 技術別市場

  • 概要
  • 比較分析
  • イオン交換高性能液体クロマトグラフィ(HPLC)
  • 免疫測定
  • ボロン酸親和性クロマトグラフィ
  • 直接酵素アッセイ
  • その他

第6章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第7章 提言

第8章 企業プロファイル

  • Abbott Laboratories
  • Alere, Inc.
  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • Chek Diagnostics (Polymer Technology Systems, Inc.)
  • Danaher Corporation (Beckman Coulter)
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • Sebia
  • Siemens Healthcare
  • 東ソー株式会社
  • Trinity Biotech plc

図表

目次

Title: Hemoglobin A1c Testing Devices Market (End-use - Laboratory and Point-of-Care Testing Devices; Technologies - Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.

This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers and research organizations involved in developing new and innovative technologies for hemoglobin A1c testing.

The market overview section of this report gives a detailed description about the market dynamics and trends including drivers, restraints and opportunities that influence the current and future scenario of this market. This section also covers market attractiveness analysis and Porter's five forces analysis to give an understanding about the competitive scenario of global hemoglobin A1C testing devices market.

The global hemoglobin A1c testing devices market is analyzed on the basis of technologies and end-uses hemoglobin A1c testing. With respect to technologies, this study considers five testing categories, namely, immunoassays, ion-exchange high performance liquid chromatography (HPLC), direct enzymatic assay, boronate affinity chromatography and others (micro-optical detection method and capillary electrophoresis). Based on the end-uses, this market is categorized into laboratory testing and point-of-care (POC) testing segments. The above segments are analyzed on the basis of their market size (revenue) for the period 2011 to 2019 in terms of USD million, along with their growth forecast in terms of CAGR (%) for the period 2013 to 2019, considering 2012 as the base year.

With respect to geographical distribution, the global hemoglobin A1C testing devices market has been classified into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). This section of report provides market size (for the period 2011 - 2019) and forecast (for the period 2013 - 2019) for each regional market in terms of USD million. The report further provides strategic recommendations, which would be helpful for the current market players and the new entrants to grow in the hemoglobin A1c testing devices market.

This report concludes with the company profiles section which includes key information about major market players. Some of the major companies profiled in this report include Abbott Laboratories, Alere, Inc., Arkray, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., A. Menarini Diagnostics, F. Hoffmann-La Roche Ltd. and Siemens Healthcare.

The global hemoglobin A1c testing devices market is categorized into the following segments:

Hemoglobin A1cTesting Devices Market, by End-use

  • Laboratory Testing Devices
  • Point-of-Care (POC)Testing Devices

Hemoglobin A1cTesting Devices Market, by Technology

  • Ion-Exchange High Performance Liquid Chromatography (HPLC)
  • Immunoassay
  • Boronate Affinity Chromatography
  • Direct Enzymatic Assay
  • Others (Micro-Optical Detection Method and Capillary Electrophoresis)

Hemoglobin A1cTesting Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.4. Research Methodology
  • 1.5. List of Abbreviations

Chapter 2 - Executive Summary

  • 2.1 Market Snapshot: Global Hemoglobin A1c Testing Devices Market
  • 2.2 Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 - Global Hemoglobin A1c Testing Devices Market Overview

  • 3.1. Introduction and Market Definition
  • 3.2. Market Drivers
    • 3.2.1. Rising Diabetic Patient Population
    • 3.2.2. Aging Population
    • 3.2.3. Proven Benefits of HbA1c Testing Leading to Rapid Adoption
  • 3.3. Market Restraints
    • 3.3.1. Higher Test Cost
    • 3.3.2. Presence of Viable Substitutes
  • 3.4. Market Opportunities
    • 3.4.1. Lucrative Market Opportunities in Emerging Economies
    • 3.4.2. Rapid Commercialization of Devices for Diagnosis of Diabetes
  • 3.5. Porter's Five Forces Analysis for the Global Hemoglobin A1c Testing Devices Market
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Competitive Rivalry
  • 3.6. Market Attractiveness Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography
  • 3.7. Competitive Landscape
    • 3.7.1. Heat Map Analysis: Global Hemoglobin A1c Testing Devices Market, by Key Players

Chapter 4 - Global Hemoglobin A1c Testing Devices Market, by End-Use

  • 4.1. Overview
    • 4.1.1. Global Hemoglobin A1c Testing Devices Market Revenue, by End-Use, 2011 - 2019 (USD Million)
  • 4.2. Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by End-Use, 2012 & 2019 (Value %)
  • 4.3. Laboratory Testing Devices
    • 4.3.1. HbA1c Laboratory Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • 4.4. Point-of-Care (POC) Testing Devices
    • 4.4.1. HbA1c Point-of-Care Testing Devices Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 - Global Hemoglobin A1c Testing Devices Market, by Technology

  • 5.1. Overview
    • 5.1.1. Global Hemoglobin A1c Testing Devices Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • 5.2. Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Technology, 2012 & 2019 (Value %)
  • 5.3. Ion-Exchange High Performance Liquid Chromatography (HPLC)
    • 5.3.1. HbA1c Ion-Exchange HPLC Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • 5.4. Immunoassay
    • 5.4.1. HbA1c Immunoassay Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • 5.5 Boronate Affinity Chromatography
    • 5.5.1. HbA1c Boronate Affinity Chromatography Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • 5.6. Direct Enzymatic Assay
    • 5.6.1. HbA1c Direct Enzymatic Assay Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • 5.7. Others
    • 5.7.1. Other HbA1c Testing Devices Technologies Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 - Global Hemoglobin A1c Testing Devices Market, by Geography

  • 6.1. Overview
    • 6.1.1. Global Hemoglobin A1c Testing Devices Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2. North America
    • 6.2.1. North America HbA1c Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe HbA1c Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • 6.4. Asia-Pacific
    • 6.4.1. Asia-Pacific HbA1c Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • 6.5. Rest of the World (RoW)
    • 6.5.1. Rest of the World HbA1c Testing Devices Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Recommendations

  • 7.1. Improving Measurement of HbA1c
  • 7.2. Investing in Emerging Economies
  • 7.3. Developing Clinical Laboratory Improvement Amendments (CLIA) Waived Tests

Chapter 8 - Company Profiles

  • 8.1. Abbott Laboratories
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. Alere, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategies
    • 8.2.5. Recent Developments
  • 8.3. ARKRAY, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. Bio-Rad Laboratories, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
    • 8.4.5. Recent Developments
  • 8.5. Chek Diagnostics (Polymer Technology Systems, Inc.)
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategies
    • 8.5.5. Recent Developments
  • 8.6. Danaher Corporation (Beckman Coulter)
    • 8.6.1. Company Overview
    • 8.6.2. Financial Overview
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategies
    • 8.6.5. Recent Developments
  • 8.7. EKF Diagnostics Holdings plc
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategies
    • 8.7.5. Recent Developments
  • 8.8. F. Hoffmann-La Roche Ltd.
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategies
    • 8.8.5. Recent Developments
  • 8.9. Menarini Group
    • 8.9.1. Company Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategies
    • 8.9.5. Recent Developments
  • 8.10. Sebia
    • 8.10.1. Company Overview
    • 8.10.2. Financial Overview
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategies
    • 8.10.5. Recent Developments
  • 8.11. Siemens Healthcare
    • 8.11.1. Company Overview
    • 8.11.2. Financial Overview
    • 8.11.3. Product Portfolio
    • 8.11.4. Business Strategies
    • 8.11.5. Recent Developments
  • 8.12. Tosoh Corporation
    • 8.12.1. Company Overview
    • 8.12.2. Financial Overview
    • 8.12.3. Product Portfolio
    • 8.12.4. Business Strategies
    • 8.12.5. Recent Developments
  • 8.13. Trinity Biotech plc
    • 8.13.1. Company Overview
    • 8.13.2. Financial Overview
    • 8.13.3. Product Portfolio
    • 8.13.4. Business Strategies
    • 8.13.5. Recent Developments

List of Figures

  • FIG. 1: Hemoglobin A1c Testing Devices Market Segmentation
  • FIG. 2: Global Hemoglobin A1c Testing Devices Market, by End-Use and Technologies, 2012 (USD Million)
  • FIG. 3: Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 4: Global Population, by Age-Group, 2000 & 2050 (%)
  • FIG. 5: Porter's Five Forces Analysis for the Global Hemoglobin A1c Testing Devices Market
  • FIG. 6: Market Attractiveness Analysis of the Global Hemoglobin A1c Testing Devices Market, by Geography
  • FIG. 7: Heat Map Analysis: Global Hemoglobin A1c Testing Devices Market, by Key Players
  • FIG. 8: Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by End-Use, 2012 & 2019 (Value %)
  • FIG. 9: HbA1c Laboratory Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10: HbA1c Point-of-Care Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: Comparative Analysis: Global Hemoglobin A1c Testing Devices Market, by Technology, 2012 & 2019 (Value %)
  • FIG. 12: HbA1c Ion-Exchange HPLC Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: HbA1c Immunoassay Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: HbA1c Boronate Affinity Chromatography Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: HbA1c Direct Enzymatic Assay Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16: Other HbA1c Testing Device Technologies Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17: North America HbA1c Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18: Europe HbA1c Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19: Asia-Pacific HbA1c Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20: Rest of the World HbA1c Testing Devices Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 21: Abbott Laboratories (Immunochemistry Segment): Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 22: Alere, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 23: Bio-Rad Laboratories, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 24: Danaher Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 25: EKF Diagnostics Holdings plc: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 26: F. Hoffmann-La Roche Ltd. (Diagnostics Business): Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 27: Menarini Group: Consolidated Turnover, 2010 - 2012 (USD Million)
  • FIG. 28: Sebia: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 29: Siemens Healthcare: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 30: Tosoh Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 31: Trinity Biotech plc: Annual Revenue, 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1: List of Abbreviations
  • TABLE 2: Market Snapshot: Global Hemoglobin A1c Testing Devices Market
  • TABLE 3: Comparing DCCT-HbA1c and IFCC-HbA1c Results
  • TABLE 4: Worldwide Diabetic Population, by Region, 2013 & 2035 (Million Individuals)
  • TABLE 5: Top 10 Countries/Territories by Diabetes Prevalence (20 years to 79 years), 2013 & 2035
  • TABLE 6: Global Hemoglobin A1c Testing Devices Market Revenue, by End-Use, 2011 - 2019 (USD Million)
  • TABLE 7: Global Hemoglobin A1c Testing Devices Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • TABLE 8: Global Hemoglobin A1c Testing Devices Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • TABLE 9: Top 5 European Countries, by Number of Diabetes Cases, 2012 (Million)
Back to Top